Illumina (NASDAQ:ILMN) sequencing machines have opened the door for genomics unlike any other company today....
Genetic tests that determine genealogy are a valuable and growing source of genetic information right...
You may have heard the term “big data” being thrown around lately. This term refers...
Illumina (NASDAQ:ILMN) has been a resounding success story for disruptive technology investors. Since their IPO...
Offering genetic testing direct to consumers is big business, with both 23andMe and Ancestry.com doing...
NantWorks is the umbrella company of Dr. Patrick Soon-Shiong, whose past achievements in building successful companies...
A few years ago we first wrote about 23andMe, the genetic testing company co-founded by...
A good disruptive technology can succeed in creating a market that didn’t exist before by...
Just last week, a rather remarkable bit of news came out which was not widely...
We’ve written a fair number of articles before about disruptive technology venture capital fund Harris...
Non invasive prenatal testing (NIPT) is a blood test used to screen pregnant women for chromosome...
In September of 2013, we highlighted Nanosphere (NASDAQ:NSPH) and their promises of high margins for...
Warning!
Well Done!
Oh snap!
